These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

186 related items for PubMed ID: 38451434

  • 1. MicroRNA-124-3p Modulates Alpha-Synuclein Expression Levels in a Paraquat-Induced in vivo Model for Parkinson's Disease.
    Esteves M, Cristóvão AC, Vale A, Machado-Pereira M, Ferreira R, Bernardino L.
    Neurochem Res; 2024 Jul; 49(7):1677-1686. PubMed ID: 38451434
    [Abstract] [Full Text] [Related]

  • 2. The influence of preconditioning with low dose of LPS on paraquat-induced neurotoxicity, microglia activation and expression of α-synuclein and synphilin-1 in the dopaminergic system.
    Kuter KZ, Śmiałowska M, Ossowska K.
    Pharmacol Rep; 2022 Feb; 74(1):67-83. PubMed ID: 34762280
    [Abstract] [Full Text] [Related]

  • 3. NADPH oxidase 1 mediates α-synucleinopathy in Parkinson's disease.
    Cristóvão AC, Guhathakurta S, Bok E, Je G, Yoo SD, Choi DH, Kim YS.
    J Neurosci; 2012 Oct 17; 32(42):14465-77. PubMed ID: 23077033
    [Abstract] [Full Text] [Related]

  • 4. High Throughput Sequencing Identifies MicroRNAs Mediating α-Synuclein Toxicity by Targeting Neuroactive-Ligand Receptor Interaction Pathway in Early Stage of Drosophila Parkinson's Disease Model.
    Kong Y, Liang X, Liu L, Zhang D, Wan C, Gan Z, Yuan L.
    PLoS One; 2015 Oct 17; 10(9):e0137432. PubMed ID: 26361355
    [Abstract] [Full Text] [Related]

  • 5. miR-101a-3p/ROCK2 axis regulates neuronal injury in Parkinson's disease models.
    Tao X, Zhang W, Chen C, Tao Y, Tao Y, Chen Z, Zhang G.
    Aging (Albany NY); 2024 May 21; 16(10):8732-8746. PubMed ID: 38775730
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Downregulation of lncRNA BACE1-AS improves dopamine-dependent oxidative stress in rats with Parkinson's disease by upregulating microRNA-34b-5p and downregulating BACE1.
    Li Y, Fang J, Zhou Z, Zhou Q, Sun S, Jin Z, Xi Z, Wei J.
    Cell Cycle; 2020 May 21; 19(10):1158-1171. PubMed ID: 32308102
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. MicroRNA expressing profiles in A53T mutant alpha-synuclein transgenic mice and Parkinsonian.
    Mo M, Xiao Y, Huang S, Cen L, Chen X, Zhang L, Luo Q, Li S, Yang X, Lin X, Xu P.
    Oncotarget; 2017 Jan 03; 8(1):15-28. PubMed ID: 27965467
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Loss of MicroRNA-7 Regulation Leads to α-Synuclein Accumulation and Dopaminergic Neuronal Loss In Vivo.
    McMillan KJ, Murray TK, Bengoa-Vergniory N, Cordero-Llana O, Cooper J, Buckley A, Wade-Martins R, Uney JB, O'Neill MJ, Wong LF, Caldwell MA.
    Mol Ther; 2017 Oct 04; 25(10):2404-2414. PubMed ID: 28927576
    [Abstract] [Full Text] [Related]

  • 13. LncRNA miR-17-92a-1 cluster host gene (MIR17HG) promotes neuronal damage and microglial activation by targeting the microRNA-153-3p/alpha-synuclein axis in Parkinson's disease.
    Zhang J, Yang Y, Zhou C, Zhu R, Xiao X, Zhou B, Wan D.
    Bioengineered; 2022 Feb 04; 13(2):4493-4516. PubMed ID: 35137671
    [Abstract] [Full Text] [Related]

  • 14. Curcumin affords neuroprotection and inhibits α-synuclein aggregation in lipopolysaccharide-induced Parkinson's disease model.
    Sharma N, Nehru B.
    Inflammopharmacology; 2018 Apr 04; 26(2):349-360. PubMed ID: 29027056
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. The nigrostriatal dopaminergic system as a preferential target of repeated exposures to combined paraquat and maneb: implications for Parkinson's disease.
    Thiruchelvam M, Richfield EK, Baggs RB, Tank AW, Cory-Slechta DA.
    J Neurosci; 2000 Dec 15; 20(24):9207-14. PubMed ID: 11124998
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.